The Dallas Asthma Brain and Cognition Study (Dallas ABC Study)

Information

  • Research Project
  • 9964886
  • ApplicationId
    9964886
  • Core Project Number
    R01HL142775
  • Full Project Number
    5R01HL142775-03
  • Serial Number
    142775
  • FOA Number
    PA-16-160
  • Sub Project Id
  • Project Start Date
    7/15/2018 - 5 years ago
  • Project End Date
    5/31/2022 - a year ago
  • Program Officer Name
    FREEMER, MICHELLE M
  • Budget Start Date
    6/1/2020 - 3 years ago
  • Budget End Date
    5/31/2021 - 2 years ago
  • Fiscal Year
    2020
  • Support Year
    03
  • Suffix
  • Award Notice Date
    7/17/2020 - 3 years ago

The Dallas Asthma Brain and Cognition Study (Dallas ABC Study)

Abstract Asthma is a chronic inflammatory airway disease, with an increasing prevalence, that is associated with a substantial burden on quality of life for patients and financial burden on society. Despite progress in the pharmacological treatment, overall asthma control remains unsatisfactory and treatment non-adherence is extremely high. The available research, much of which was conducted by investigators on this proposal, suggests that asthma may be associated with changes in brain structure and biochemistry, as well as increased risk for cognitive impairment and dementia. However, little is known about the impact of asthma on cognitive function and associated central nervous system processes, especially for in middle- to older age patients. Prior research has also not characterized the relationship between key domains of cognitive function and possible changes in brain structure, chemistry, and function specific to asthma. Additionally, the role of biobehavioral factors (such as mood, sleep, or inflammation) and asthma-specific factors (severity, duration, medication, airway inflammation) in explaining some of these deficits in asthma and aging has not been explored. We therefore propose to compare 126 adults 40-69 years old, diagnosed with asthma, and stratified for age (three decades) and asthma severity, with 66 age-matched non-asthmatic controls using cognitive tests that include processing speed, episodic memory, and executive function. Participants will also undergo neuroimaging. Structural magnetic resonance imaging (MRI) will focus on hippocampal volume. Diffusion tensor imaging (DTI) will be used to measure integrity of white matter integrity, which is associated with processing speed. Proton magnetic resonance spectroscopy (1HMRS) will measure metabolites linked to neuronal degeneration (N-acetyl aspartate, NAA) and glial inflammation (myo-inositol, mI). Three functional MRI scans will measure brain activity under different cognitive conditions: (a) a resting state scan to examine functional connectivity of brain networks; (b) a subsequent memory task to assess the role of hippocampal activation in the service of memory encoding, and (c) a modulation task that measures the ability of the cognitive control network to increase brain activity in fronto-parietal regions as task demands increase. We will also examine whether cognitive impairments are mediated by distinct brain changes extrapolated from prior research on aging and pilot research on respiratory disease. In addition, we will study a potential role of depressive mood, sleep quality and systemic inflammation, as well as asthma-relevant variables in mediating these associations. We hypothesize that asthma patients, compared to controls, will demonstrate accelerated brain aging as demonstrated by cognitive deficits and brain changes, which increase in magnitude with older age. Thus, this proposal will provide fundamental information to develop future preventative and intervention efforts to mitigate the potentially adverse effects of asthma on brain and cognition. A multidisciplinary research team with extensive experience in mental health in asthma patients, as well as neuroimaging across the lifespan will conduct the study.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R01
  • Administering IC
    HL
  • Application Type
    5
  • Direct Cost Amount
    649389
  • Indirect Cost Amount
    83352
  • Total Cost
    732741
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    838
  • Ed Inst. Type
    SCHOOLS OF ARTS AND SCIENCES
  • Funding ICs
    NHLBI:732741\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    BMIO
  • Study Section Name
    Behavioral Medicine, Interventions and Outcomes Study Section
  • Organization Name
    SOUTHERN METHODIST UNIVERSITY
  • Organization Department
    PSYCHOLOGY
  • Organization DUNS
    001981133
  • Organization City
    DALLAS
  • Organization State
    TX
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    752750302
  • Organization District
    UNITED STATES